RZRanran Zhou

Ranran Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ranran Zhou has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Wanlong Tan

    Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province 510000, China

    3 shared publications
  • Bahaerguli Muhuitijiang

    Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China

    2 shared publications
  • Bahaerguli Muhuitijiang

    Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510080, Guangdong, China; The First Clinical Medical College, Southern Medical University, Guangzhou 510080, Guangdong, China

    2 shared publications
  • Cundong Liu

    Department of Developmental Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510630, China

    2 shared publications
  • Jiawei Zhou

    Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou 510080, Guangdong, China; The First Clinical Medical College, Southern Medical University, Guangzhou 510080, Guangdong, China

    2 shared publications
  • Shikai Deng

    Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510080, Guangdong, China

    2 shared publications

Latest Publications

  • Open Access

    Seminal Extracellular Vesicles LGALS3BP as a Potential Biomarker of Varicocele‐Associated Infertility in TMT‐Based Quantitative Proteomic Analysis

    byĀ Cheng Yang, Jian-Xiong Li, Xian-Yuan Lv, Ran-Ran Zhou, Jun-Hao Zhou, Cun-Dong Liu, Shan-Chao Zhao

    The proteomic analysis of seminal plasma (SP) is a powerful tool for screening and identifying potential novel biomarkers of male infertility. However, the proteomic composition of seminal extracellular (SE) vesicles in varicocele (VC) is still poorly characterized. The main objective of the present study was to compare the proteome of SEs between infertile men with VC and fertile men without VC and to reveal differentially expressed SEs proteins (DESEPs) that can serve as potential novel biomarkers of VC‐associated infertility. SEs were isolated and purified from SP, and SEs proteins were extracted and labeled with TMT and analyzed by high‐resolution LC‐MS/MS. A total of 1457 proteins were quantitatively identified in these SEs samples. Of these proteins, 175 DESEPs (76 upregulated and 99 downregulated) were identified. Bioinformatics analysis indicated that the molecular functions and biological processes of these DESEPs were involved in metabolism, cell growth and/or maintenance, energy pathways, transport, and cell activation. Among these DESEPs of interest, PGK2 and LGALS3BP were validated by Western blotting. The expression level of the SEs LGALS3BP was also determined by ELISA. A significant positive association was observed between the concentration of SEs LGALS3BP and clinical characteristics. Moreover, receiver operating characteristic (ROC) curve analysis showed that SEs LGALS3BP had better predictive efficacy than seminal LGALS3BP as a potential diagnostic biomarker of VC‐associated infertility. Differences in the SEs protein profiles indicate that DESEPs may serve as potential biomarkers for VC‐associated infertility.


  • Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer

    byĀ Ranran Zhou, Jiawei Zhou, Shikai Deng, Yuanchao Zhu, Bahaerguli Muhuitijiang, Jiaxu Wu, Wanlong Tan


  • Open Access

    Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity

    byĀ Jiawei Zhou, Ranran Zhou, Yuanchao Zhu, Shikai Deng, Bahaerguli Muhuitijiang, Chengyao Li, Xiaojun Shi, Ling Zhang, Wanlong Tan

    Background: Regulatory B cells (Bregs), a specialized subset of B cells that modulate immune responses and maintain immune tolerance in malignant tumors, have not been extensively investigated in the context of bladder cancer (BLCA). This study aims to elucidate the roles of Bregs and Breg-related genes in BLCA. Methods: We assessed Breg infiltration levels in 34 pairs of BLCA and corresponding paracancerous tissues using immunohistochemical staining. We conducted transwell and wound healing assays to evaluate the impact of Bregs on the malignant phenotype of SW780 and T24 cells. Breg-related genes were identified through gene sets and transcriptional analysis. The TCGA-BLCA cohort served as the training set, while the IMvigor210 and 5 GEO cohorts were used as external validation sets. We employed LASSO regression and random forest for feature selection and developed a risk signature using Cox regression. Primary validation of the risk signature was performed through immunohistochemical staining and RT-qPCR experiments using the 34 local BLCA samples. Additionally, we employed transfection assays and flow cytometry to investigate Breg expansion ability and immunosuppressive functions. Results: Breg levels in BLCA tissues were significantly elevated compared to paracancerous tissues (P < 0.05) and positively correlated with tumor malignancy (P < 0.05). Co-incubation of SW780 and T24 cells with Bregs resulted in enhanced invasion and migration abilities (all P < 0.05). We identified 27 Breg-related genes, including CD96, OAS1, and CSH1, which were integrated into the risk signature. This signature demonstrated robust prognostic classification across the 6 cohorts (pooled HR = 2.25, 95% CI = 1.52–3.33). Moreover, the signature exhibited positive associations with advanced tumor stage (P < 0.001) and Breg infiltration ratios (P < 0.05) in the local samples. Furthermore, the signature successfully predicted immunotherapeutic sensitivity in three cohorts (all P < 0.05). Knockdown of CSH1 in B cells increased Breg phenotype and enhanced suppressive ability against CD8 + T cells (all P < 0.05). Conclusions: Bregs play a pro-tumor role in the development of BLCA. The Breg-related gene signature established in this study holds great potential as a valuable tool for evaluating prognosis and predicting immunotherapeutic response in BLCA patients.


  • Open Access

    An artificial neural network model to diagnose non-obstructive azoospermia based on RNA-binding protein-related genes

    byĀ Fan Peng, Bahaerguli Muhuitijiang, Jiawei Zhou, Haoyu Liang, Yu Zhang, Ranran Zhou

    Non-obstructive azoospermia (NOA) is a severe form of male infertility, but its pathological mechanisms and diagnostic biomarkers remain obscure. Since the dysregulation of RNA-binding proteins (RBPs) had nonnegligible effects on spermatogenesis, we aimed to investigate the functions and diagnosis values of RBPs in NOA. 58 testicular samples (control = 11, NOA = 47) from Gene Expression Omnibus (GEO) were set as the training cohort. Three public datasets, containing GSE45885 (control = 4, NOA = 27), GSE45887 (control = 4, NOA = 16), and GSE145467 (control = 10, NOA = 10), and 44 clinical samples from the local hospital (control = 27, NOA = 17) were used for validation. Through a series of bioinformatical analyses and machine learning algorithms, including genomic difference detection, protein-protein interaction network analysis, LASSO, SVM-RFE, and Boruta, DDX20 and NCBP2 were determined as significant predictors of NOA. Single-cell RNA sequencing of 432 testicular cell samples from NOA patients indicated that DDX20 and NCBP2 were associated with spermatogenesis (false discovery rate < 0.05). Based on the transcriptome expressions of DDX20 and NCBP2, we constructed multiple diagnosis models using logistic regression, random forest, and artificial neural network (ANN). The ANN model exhibited the most reliable predictive performance in the training cohort (AUC = 0.840), GSE45885 (AUC = 0.731), GSE45887 (AUC = 0.781), GSE145467 (AUC = 0.850), and local cohort (AUC = 0.623). Totally, an ANN diagnosis model based on RBP DDX20 and NCBP2 was developed and externally validated in NOA, functioning as a promising tool in clinical practice.


  • Construction and experimental validation of a B cell senescence–related gene signature to evaluate prognosis and immunotherapeutic sensitivity in bladder cancer

    byĀ Ranran Zhou, Jiawei Zhou, Bahaerguli Muhuitijiang, Wanlong Tan

    Senescent B cells exhibit reduced antibody production and enhanced proinflammatory cytokine and chemokine secretion, exerting non-negligible functions in antitumor immunity. This study aims to clarify the prognosis value of B cell senescence–related genes in bladder cancer (BLCA). Twelve B cell senescence–related genes were identified based on previous studies and the single-cell RNA sequencing of a BLCA sample from Gene Expression Omnibus (GEO). The Cancer Genome Atlas BLCA cohort was used as the training dataset. Three cohorts from GEO, 35 clinical samples from the local hospital, and in vitro cell experiments were used for validation. The unsupervised clustering based on the 12 genes was associated with the prognosis and the tumor immunity. Through least absolute shrinkage and selection operator regression and random forest algorithm, G protein subunit gamma 11 (GNG11) and inhibitor of DNA binding 1 (ID1) of the 12 genes were determined as significant prognosis predictors and then included in the multivariate Cox regression model. The model was a reliable and robust prognosis biomarker across multiple large-scale cohorts (pooled HR = 1.76, 95% CI = 1.41–2.20). The tight association between the model and BLCA malignant degree was demonstrated in the local cohort (P < 0.01). The model could also predict the immunotherapeutic sensitivity, which was confirmed by the tumor immune dysfunction and exclusion algorithm (P < 0.0001) and IMvigor210 cohort (P < 0.0001). At last, in vitro cell experiments in IM-9 and GM12878 B cells indicated that GNG11 and ID1 were involved in the cellular aging process. Collectively, a B cell senescence–related gene signature was constructed to evaluate the prognosis and immunotherapeutic response in BLCA, providing novel insights into the biological mechanisms.


  • Open Access

    An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer

    byĀ Ranran Zhou, Jingjing Liang, Hu Tian, Qi Chen, Cheng Yang, Cundong Liu

    Immunosenescence refers to the immune system undergoing a series of degenerative changes with advancing age and is tightly associated with the initiation and progression of cancers. However, the immunosenescence-related genes as critical biomarkers for bladder cancer (BLCA) have not been systematically analyzed. We retrieved the immunosenescence-related genes from the public database and verified their association with hallmarks of immunosenescence based on The Cancer Genome Atlas (TCGA) cohort. Through gene pairing, Lasso, and univariate Cox regression, an 8-gene pair model was constructed to evaluate the overall survival of BLCA, which was then validated in the training cohort ( ), two external validation cohorts ( ; ), and local samples ( ). We also downloaded the clinical information and gene expression matrices of other 32 different cancers from TCGA. The established model showed significant predictive value for the prognosis in 15 cancers ( ). The risk model could also serve as a promising predictor for immunotherapeutic response, which has been verified by the TIDE algorithm ( ), IMvigor210 dataset ( ), and other two datasets correlated with immunotherapy ( ; ). The TCGA dataset, in vitro cell experiments, and pan-cancer analysis displayed that the gene signature was associated with cisplatin sensitivity (<use...